<DOC>
	<DOCNO>NCT03082430</DOCNO>
	<brief_summary>This monocentric protocol design evaluate efficacy therapeutic management symptomatic knee osteoarthritis ( resistant medical first-line treatment ) intra-articular injection autologous PRP prepare procedure use dedicate CE mark medical device validate reproducible method preparation</brief_summary>
	<brief_title>GO PRP : Assessing Efficacy Intra Articular Injection Platelets Rich Plasma Gonarthrosis Treatment Routine Care</brief_title>
	<detailed_description>The main objective get 50 % proportion responder define answer `` absent '' `` light '' KOOS questionnaire question pain difficulty walk flat ground . Secondary objective include safety validation use PRP ( prepared standardize manner mean give medical device ) second-line standard care osteoarthritis introduction systematic monitoring ; feasibility health care system dedicate treatment knee osteoarthritis autologous PRP . Furthermore , secondary objective monitor follow evolution pain ( VAS ) knee function ( KOOS score ) 1 month , 3 month , 6 month . Evaluation MRI perform within 15 day prior ( inclusion visit ) injection 6 month assess cartilage thickness visualize regenerative effect .</detailed_description>
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Osteoarthritis , Knee</mesh_term>
	<criteria>Men woman 20 80 year Gonarthrosis diagnostic objectify criterion American College Rheumatology Joint pain 6 month Answer `` moderate '' question pain walk flat ground Answer `` moderate '' question trouble walk flat ground Osteoarthritis stage 2 3 scale Kellgren Lawrence ( objectified radiography ) within 6 month previous inclusion Axial deformation less equal 5 ° low limb Informed consent sign patient HB &gt; 10g / dl BetaHCG negative baseline Ability perform procedure followup ( 50 walk flat surface / stair ) . Being affiliated system health insurance Exclusion criterion : Axial deformation &gt; 5 ° Ligamentous instability Significant injuries target knee knee surgery contralateral side 12 month previous inclusion visit Ligament reconstruction 12 month précédants inclusion visit Need cane assistance move BMI &gt; 35 Thrombocytopenia &lt; 150 G / L Thrombocytosis &gt; 450 G / L Known thrombopathy Anemia HB &lt; 10g / dl Active infection HIV 1 2 , Agp24 , HCV Ab , Ag HbS AcHbc , Ac HTLV I II , TPHA Chronic treatment corticosteroid per o old 2 week Injection intraarticular corticosteroid le 2 month Intraarticular injection hyaluronic acid le 6 month NSAIDs antiplatelet agent le 15 day Inability stop NSAIDs ( include aspirin ) 15 day injection week follow injection Fever recent illness Autoimmune diseases Inflammatory arthritis Immune deficiency Infectious diseases Pregnant woman Adults legally protect ( guardianship trusteeship ) People simultaneously participate biomedical research16 . Inability</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>